DONALD FOSTER: Open Payments
NPI 1679960066 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 9 payments from 7 companies in 2025. Trend: 2023 $721 · 2024 $214 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $70 |
| Alkermes, Inc. | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Braeburn Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: VRAYLAR, VIVITROL, MOUNJARO, CAPLYTA, BRIXADI, MAVYRET, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
